Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antioxidant Eye Drops for Dry Eye in Diabetic Retinopathy
NCT05429229Phase 2Unknown
- Start
- Nov 2021
- Primary completion
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of VisuXL in dry eye syndrome (DED). Status: unknown.
02
Drugs
VisuXL
03
Conditions
dry eye syndrome (DED)
Beyond the preview
Go deeper on NCT05429229.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05429229.